Investigation of the Accuracy of an Automated Refractor to Provide Well-tolerated Eyeglass Prescriptions

NCT ID: NCT06883032

Last Updated: 2025-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

92 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-16

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

At the New England College of Optometry in Boston, MA, subjects ages 18-65 who have received or are receiving treatment for refractive error who choose to enroll in the study will be evaluated using subjective refraction and automated refraction, by way of the QuickSee Plus refractor. Subjects will then be randomized into one of two treatment plans: receive glasses from automated refraction first then subjective refraction second, and vice versa. After one week of wearing the first pair of glasses, patient preferences are assessed, and glasses are switched. After a week of wearing the second pair of glasses from the alternate measurement method, patient preferences are again assessed. Patients may then decide which pair patient like best. This is a triple blind, case-crossover clinical trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Refractive Errors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Assignment
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AR Eyeglasses, then SR Eyeglasses

Automated Refraction (AR) Eyeglasses, then Subjective Refraction (SR) Eyeglasses

Group Type OTHER

AR Eyeglasses first, SR Eyeglasses second

Intervention Type OTHER

First Eyeglasses based on Automated Refraction, Second Eyeglasses based on Subjective Refraction

SR Eyeglasses, then AR Eyeglasses

Subjective Refraction (SR) Eyeglasses, then Automated Refraction (AR) Eyeglasses

Group Type OTHER

SR Eyeglasses first, AR Eyeglasses second

Intervention Type OTHER

First Eyeglasses based on Subjective Refraction, Second Eyeglasses based on Automated Refraction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AR Eyeglasses first, SR Eyeglasses second

First Eyeglasses based on Automated Refraction, Second Eyeglasses based on Subjective Refraction

Intervention Type OTHER

SR Eyeglasses first, AR Eyeglasses second

First Eyeglasses based on Subjective Refraction, Second Eyeglasses based on Automated Refraction

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* who have had an eye exam at the NECO Center for Eye Care of Commonwealth or Roslindale
* who are aged between 18 years and 65 years

Exclusion Criteria

* whose refractive error is outside of the detection range of the QuickSee Free Pro and QuickSee Plus devices: -13 D to +10 D (S) and -8 D to + 8 D (C)
* who are unable to provide consent
* who have undergone any eye surgery
* who have a history of ocular disease
* who are taking systemic drugs
* who wear more than one pair of single vision eyeglasses for distance
* who more than occasionally wear soft contact lenses
* who are unable and unwilling to wear the eyeglasses provided by the study for the required duration
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

New England College of Optometry

OTHER

Sponsor Role collaborator

National Eye Institute (NEI)

NIH

Sponsor Role collaborator

PlenOptika, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shivang R. Dave, PhD

CEO & co-founder

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New England College of Optometry (NECO) Center for Eye Care of Commonwealth

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Joseph S, Varadaraj V, Dave SR, Lage E, Lim D, Aziz K, Dudgeon S, Ravilla TD, Friedman DS. Investigation of the Accuracy of a Low-Cost, Portable Autorefractor to Provide Well-Tolerated Eyeglass Prescriptions: A Randomized Crossover Trial. Ophthalmology. 2021 Dec;128(12):1672-1680. doi: 10.1016/j.ophtha.2021.05.030. Epub 2021 Jun 7.

Reference Type BACKGROUND
PMID: 34111444 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2R44EY025452-04

Identifier Type: NIH

Identifier Source: secondary_id

View Link

QuickSee Plus Trial

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Berkeley Orthokeratology Study
NCT00000123 COMPLETED PHASE3